Our mission and focus is straightforward: to invest in research aimed at finding the fastest possible route to a cure. We understand that brain tumor and cancer patients are in desperate need of new, effective treatments. To advance the most promising leads we partner with world renowned researchers to bring new treatments to patients as quickly as possible.
In total, Accelerate Brain Cancer Cure has awarded over $20 million to fund brain tumor and brain cancer research. Our research projects are quite diverse: ranging from creating targeted therapeutics to improving drug delivery to developing new preclinical screening mouse models to honing diagnostic biomarkers. A common characteristic of these projects is that most would not have moved forward without our funding.
We invest in each stage of the therapeutic development pipeline. Our Pre-Clinical Screening Program breaks down barriers to entry, our research grants focus on novel therapies, and our investments with companies allow us to bring the most promising treatments to patients quickly.
Click here to learn more about our 2011 key accomplishments.